Potent Antidiabetic Activity of Ethanolic Extract of Terminalia Arjuna Fruits on Streptozotocin-Induced Diabetic Wistar Albino Rats
Pharmaceutical Science-Pharma
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.P87-97Keywords:
Diabetes, Antihyperlipidemic, Terminalia Arjuna, Fruits, Streptozotocin, and Antioxidant.Abstract
Diabetes mellitus is the most common chronic endocrine and metabolic disorder, impacts the quality of life, and has become the leading cause of death worldwide. Now a day’s, herbal drugs are in great demand for the treatment of diabetes because of their traditional acceptability, lesser side effects, and adverse effects compared with allopathic medications. Terminalia arjuna fruits were selected for the study due to their abundant availability and based on ethanomedicinal folk claims. The fruits of Terminalia arjuna have been evaluated for their antidiabetic and antihyperlipidemic activities using streptozotocin-induced diabetic Wistar albino rats. In the study, two doses of ethanolic extract of Terminalia arjuna fruits (TAF) were selected and administered to normal rats for an oral glucose tolerance test. For an antidiabetic study in streptozotocin-induced diabetic rats, the effect of the extract was observed for 28 days for blood glucose alterations. All experimental animals were observed for weight changes, due to STZ-induced diabetes, and were found to be significantly reverted to normal in all animals except the diabetic control group. After the completion of the experimental period, the collected serum samples were subjected to various biochemical parameters studied, including a lipid profile, glycosylated hemoglobin (HbA1c), urea, and creatinine level. An antioxidant study was performed using collected tissues, followed by histopathological studies of the pancreas. The research study revealed that the TAF extract has significant antidiabetic activity and the potential to revert the altered lipid profile and increase HbA1c to normal. TAF extract significantly normalized the urea, creatinine, superoxide dismutase, catalase, and glutathione peroxidase levels. Thus, the study concluded that TAF extract exhibits significant (p>0.05) antidiabetic activity in STZ-induced diabetic rats.
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(1);Suppl 1:S67-74. doi: 10.2337/dc13-S067, PMID 23264425.
Rorsman P, Ashcroft FM. Pancreatic β-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117-214. doi: 10.1152/physrev.00008.2017, PMID 29212789.
Mazumder PM, Rathinavelusamy P, Sasmal D. Role of antioxidants in phytomedicine with special reference to antidiabetic herbs. Asian Pac J Trop Dis. 2012;2:S969-79. doi: 10.1016/S2222-1808(12)60303-X.
Manandhar Shrestha JTM, Shrestha H, Prajapati M, Karkee A, Maharjan A. Adverse effects of oral hypoglycemic agents and adherence to them among patients with type 2 diabetes mellitus in Nepal. J Lumbini Med Coll. 2017;5(1):34-40. doi: 10.22502/jlmc.v5i1.126.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs are used for the treatment of diabetes. J Clin Biochem Nutr. 2007;40(3):163-73. DOI: 10.3164/jcbn.40.163, PMID 18398493.
Chaudhari GM, Mahajan RT. A comprehensive study on pharmacognostic, physico, and phytochemical evaluation of Terminalia arjuna Roxb. stem bark. J Pharmacogn Phytochem. 2015;4:186-93.
Ragavan B, Krishnakumari S. Antidiabetic effect ofT. arjuna bark extract in alloxan induced diabetic rats. Indian J Clin Biochem. 2006;21(2):123-8. doi: 10.1007/BF02912926, PMID 23105628.
Biswas M, Kar B, Bhattacharya S, Kumar RBS, Ghosh AK, Haldar PK. Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol. 2011;49(4):335-40. doi: 10.3109/13880209.2010.516755, PMID 21281245.
Singh S, Shukla N, Bhowmick M, Rathi J. Evaluation of antidiabetic activity of Terminalia arjuna root extract in alloxan induced diabetic rats. JBPR. 2019;8(1). doi: 10.32553/jbpr.v8i1.566.
Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review. J Tradit Complement Med. 2017;7(1):65-78. doi: 10.1016/j.jtcme.2016.02.003, PMID 28053890.
Kokate CK, Purohit AP, Gokhale SB. A text book of Pharmacognosy. NiraliPrakashan Pune. 1995;4(40):1-20.
Harborne JB. Phytochemical methods. London: Chapman & Hall; 1973. p. 49-188.
Trease GE, Evans WC. Drugs of biological origin. Pharmacognosy. 1983:309-540.
Soni LK, Dobhal MP, Arya D, Bhagour K, Parasher P, Gupta RS. In vitro and in vivo antidiabetic activity of isolated fraction of Prosopis cineraria against streptozotocin-induced experimental diabetes: A mechanistic study. Biomed Pharmacother. 2018;108:1015-21. DOI: 10.1016/j.biopha.2018.09.099, PMID 30372801.
Sharma U, Sahu R, Roy A, Golwala D. In vivo antidiabetic and antioxidant potential of Stephania hernandifolia in streptozotocin-induced-diabetic rats. J Young Pharm. 2010;2(3):255-60. doi: 10.4103/0975-1483.66803, PMID 21042481.
Erukainure OL, Ebuehi OAT, Adeboyejo FO, Aliyu M, Elemo GN. Hematological and biochemical changes in diabetic rats fed with fiber-enriched cake. J Acute Med. 2013;3(2):39-44. doi: 10.1016/j.jacme.2013.03.001.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. doi: 10.1093/clinchem/18.6.499, PMID 4337382.
Patra S, Bhattacharya S, Bala A, Haldar PK. Antidiabetic effect of Drymaria cordata leaf against streptozotocin-nicotinamide-induced diabetic albino rats. J Adv Pharm Technol Res. 2020;11(1):44-52. doi: 10.4103/japtr.JAPTR_98_19, PMID 32154158.
Gupta V, Kori ML. Assessment of hepatic and nephroprotective potential of polyherbal combinations against STZ-induced diabetic liver and kidney complications in Wistar rats. ap. 2022;11(1):311-9. DOI: 10.54085/ap.2022.11.1.32.
Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alex J Med. 2018;54(4):287-93. doi: 10.1016/j.ajme.2017.09.001.
Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582(1):67-78. doi: 10.1016/0304-4165(79)90289-7, PMID 760819.
Dwivedi S, Chopra D. Revisiting Terminalia arjuna - an ancient cardiovascular drug. J Tradit Complement Med. 2014;4(4):224-31. doi: 10.4103/2225-4110.139103, PMID 25379463.
Variya BC, Bakrania AK, Madan P, Patel SS. Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice. Regul Toxicol Pharmacol. 2019;101:71-8. doi: 10.1016/j.yrtph.2018.11.010, PMID 30465803.
Chaim-aom N, Chomko S, Talubmook CToxicology and Oral glucose Tolerance Test (OGTT) of Thai Medicinal Plant Used for Diabetes controls, Phyllanthus acidus L. (EUPHORBIACEAE). Pharmacogn J. 2016;9(1):58-61. doi: 10.5530/pj.2017.1.11.
Kumar A, Lingadurai S, Shrivastava TP, Bhattacharya S, Haldar PK. Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats. Pharm Biol. 2011;49(6):577-82. doi: 10.3109/13880209.2010.529615, PMID 21281246.
Kasabri V, Flatt PR, Abdel-Wahab YHA. Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. Br J Nutr. 2010;103(2):212-7. doi: 10.1017/S0007114509991577, PMID 19723351.
Abu-Lebdeh HS, Nair KS. Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab. 1996 Oct;10(4):589-601. doi: 10.1016/s0950-351x(96)80741-5. PMID 9022953.
Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246-58. DOI: 10.4239/wjd.v6.i13.1246, PMID 26468341.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95-104. doi: 10.4137/BMI.S38440, PMID 27398023.
Evan AP, Mong SA, Gattone VH, Connors BA, Aronoff GR, Luft FC. The effect of streptozotocin and streptozotocin-induced diabetes on the kidney. Ren Physiol. 1984;7(2):78-89. doi: 10.1159/000172927, PMID 6231704.
Amartey NA, Nsiah K, Mensah FO. Plasma levels of uric acid, urea and creatinine in diabetics who visit the clinical analysis laboratory (can-lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. J Clin Diagn Res. 2015;9(2):BC05-9. doi: 10.7860/JCDR/2015/10905.5530, PMID 25859443.
Bajaj S, Khan A. Antioxidants and diabetes. Indian J Endocrinol Metab. 2012;16(Suppl 2):S267-71. doi: 10.4103/2230-8210.104057, PMID 23565396.
Kim JO, Kim KS, Lee GD, Kwon JH. Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats. J Med Food. 2009;12(4):728-35. DOI: 10.1089/jmf.2008.1195, PMID 19735171.
Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Medicines (Basel, Switzerland). 2018;5(3):93. DOI: 10.3390/medicines5030093, PMID 30149600.
Zhong F, Jiang Y. Endogenous pancreatic β cell regeneration: A potential strategy for the recovery of β cell deficiency in diabetes. Front Endocrinol. 2019;10:101. DOI: 10.3389/fendo.2019.00101, PMID 30842756.
Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013;9(1):25-53. doi: 10.2174/157339913804143225, PMID 22974359.
Kumar V, Ahmed D, Anwar F, Ali M, Mujeeb M. Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2I → 1II)-α-D-glucopyranoside in streptozotocin-induced diabetic rats. Springerplus. 2013;2:639. doi: 10.1186/2193-1801-2-639, PMID 24349947.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Pradeep Adlak, Rakesh Sagar, Mohan Lal Kori
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
